黑色素瘤脑转移中放疗与免疫检查点抑制剂的序贯影响
该回顾性分析纳入手术切除后的黑色素瘤脑转移患者,比较放疗(RT)与免疫检查点抑制剂(ICI)联合或单用的生存差异,并通过RNA测序和小鼠模型验证序贯顺序。结果显示RT联合ICI优于单纯RT,且先RT后ICI优于先ICI后RT,临床前模型支持该序贯优势。
要点
- 切除后黑色素瘤脑转移患者中,RT联合ICI生存优于单纯RT。
- 联合治疗中先RT后ICI序贯优于先ICI后RT。
- 临床前模型支持先RT后抗PD-L1治疗优于反向序贯。
核心结论
- 手术切除后的黑色素瘤脑转移患者中,RT联合ICI生存优于单纯RT,且先RT后ICI序贯优于先ICI后RT。
研究设计与样本
- 回顾性分析接受RT、ICI或RT联合ICI治疗的手术切除后黑色素瘤脑转移患者。
- 对联合治疗患者按先RT后ICI与先ICI后RT分组,行RNA测序比较差异基因表达。
- 采用糖蛋白转导的同系黑色素瘤小鼠模型进行验证实验。
主要发现
- 切除后黑色素瘤脑转移患者中,RT联合ICI较单纯RT生存更优。
- 先RT后ICI组较先ICI后RT组生存更优。
- 先RT后ICI组中凋亡信号相关基因及NF-κB信号相关炎症关键调节因子出现失调。
- 临床前模型中先RT后抗PD-L1治疗优于反向序贯。
临床怎么用
- 对于手术切除后的黑色素瘤脑转移患者,可考虑RT联合ICI治疗。
- 联合治疗时优先考虑先RT后ICI的序贯顺序。
局限性
- 本研究为回顾性分析,需前瞻性研究验证最佳序贯顺序。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Melanoma brain metastases (MBM) occur in ∼50% of melanoma patients. Although both radiation therapy (RT) and immune checkpoint inhibitor (ICI) are used alone or in combination for MBM treatment, the role of this combination and how these treatments could best be sequenced remains unclear. METHODS AND MATERIALS: We conducted a retrospective analysis of patients with resected MBM who underwent treatment with RT, ICI, or a combination of RT and ICI. Among the latter, we specifically investigated the differential gene expression via RNA-sequencing between patients who received RT first then ICI (RT → ICI) versus ICI first then RT (ICI → RT). We used a glycoprotein-transduced syngeneic melanoma mouse model for validation experiments. RESULTS: We found that for patients with resected MBM, a combination of RT and ICI confers superior survival compared with RT alone. Specifically, we found that RT → ICI was superior compared with ICI → RT. Transcriptome analysis of resected MBM revealed that the RT → ICI cohort demonstrated deregulation of genes involved in apoptotic signaling and key modulators of inflammation that are most implicated in nuclear factor kappa-light-chain-enhancer of activated B cells signaling. In a preclinical model, we showed that RT followed by anti-programmed death-ligand 1 therapy was superior to the reverse sequence of therapy, supporting the observations we made in patients with MBM. CONCLUSIONS: Our study provides initial insights into the optimal sequence of RT and ICI in the treatment of MBM after surgical resection. Prospective studies examining the best sequence of RT and ICI are necessary, and our study contributes to the rationale to pursue these.
引用
- Pomeranz Krummel DA, Nasti TH, Izar B, et al. Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. Int J Radiat Oncol Biol Phys. 2020. PMID: 32057994. doi:10.1016/j.ijrobp.2020.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。